Cargando…

Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy

INTRODUCTION: Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable disease not yet under control. In Italy, although different anti-meningococcal vaccines are available, their offer among regions is heterogeneous. The aim of this study is to describe the epidemiology of...

Descripción completa

Detalles Bibliográficos
Autores principales:	IGIDBASHIAN, S., BERTIZZOLO, L., TOGNETTO, A., AZZARI, C., BONANNI, P., CASTIGLIA, P., CONVERSANO, M., ESPOSITO, S., GABUTTI, G., ICARDI, G., LOPALCO, P.L., VITALE, F., PARISI, S., CHECCUCCI LISI, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore Srl 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419122/ https://www.ncbi.nlm.nih.gov/pubmed/32802999 http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.2.1589

Ejemplares similares

Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations
por: ICARDI, GIANCARLO, et al.
Publicado: (2020)

A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use
por: AZZARI, C., et al.
Publicado: (2018)

Meningococcal B vaccination strategies and their practical application in Italy
por: GASPARINI, R., et al.
Publicado: (2015)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
por: Azzari, Chiara, et al.
Publicado: (2021)

Underestimation of Invasive Meningococcal Disease in Italy
por: Azzari, Chiara, et al.
Publicado: (2016)

Four-Component Recombinant Protein–Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy
por: Lodi, Lorenzo, et al.
Publicado: (2023)

Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic: Appeal from the Board of the Vaccination Calendar for Life in Italy: Maintain and increase coverage also by re-organizing vaccination services and reassuring the population
por: Bonanni, P., et al.
Publicado: (2021)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
por: Bonanni, Paolo, et al.
Publicado: (2019)

Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015–2018
por: Andrianou, Xanthi D., et al.
Publicado: (2021)

Human respiratory syncytial virus and hospitalization in young children in Italy
por: Kuhdari, Parvanè, et al.
Publicado: (2018)

Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign?
por: BECHINI, A., et al.
Publicado: (2018)

European decision-maker perspective with regard to influenza prevention policies
por: Lopalco, P.L.
Publicado: (2016)

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine; Infanrix™ hexa: Twelve years of experience in Italy
por: Baldo, Vincenzo, et al.
Publicado: (2014)

Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy
por: Bonanni, Paolo, et al.
Publicado: (2021)

In the Digital Era, Is Community Outrage a Feasible Proxy Indicator of Emotional Epidemiology? The Case of Meningococcal Disease in Sardinia, Italy
por: Dettori, Marco, et al.
Publicado: (2018)

Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
por: Boccalini, Sara, et al.
Publicado: (2020)

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
por: Gasparini, Roberto, et al.
Publicado: (2016)

Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019)
por: Riccò, Matteo, et al.
Publicado: (2023)

Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy
por: Holl, Katsiaryna, et al.
Publicado: (2016)

Influenza vaccination 2014–2015: Results of a survey conducted among general practitioners in Italy
por: Levi, Miriam, et al.
Publicado: (2018)

Estimates of the burden of meningococcal disease in Italy: implications for prevention and control
por: MARTINELLI, D., et al.
Publicado: (2015)

Is primary meningococcal arthritis in children more frequent than we expect? Two pediatric case reports revealed by molecular test
por: Ricci, S., et al.
Publicado: (2018)

Point prevalence survey on healthcare-associated infections in Apulian region, Italy, 2022-2023
por: Fortunato, F, et al.
Publicado: (2023)

Herpes Zoster: the rationale for the introduction of vaccination in Italy
por: PAGANINO, C., et al.
Publicado: (2015)

Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy
por: GENOVESE, C., et al.
Publicado: (2019)

Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012–2019
por: Barbieri, Elisa, et al.
Publicado: (2023)

Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?
por: Bonanni, Paolo, et al.
Publicado: (2015)

Impact of vaccination on invasive pneumococcal disease in Italy 2007–2017: surveillance challenges and epidemiological changes
por: Monali, R., et al.
Publicado: (2020)

Meningococcal disease in Italy: public concern, media coverage and policy change
por: Covolo, Loredana, et al.
Publicado: (2019)

Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
por: Boccalini, Sara, et al.
Publicado: (2023)

1139. Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Compared to a Meningococcal Reference Vaccine (MCV4-TT) in Healthy Adolescents
por: Díez-Domingo, Javier, et al.
Publicado: (2023)

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012
por: LEVI, M., et al.
Publicado: (2014)

Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives
por: SIGNORELLI, C., et al.
Publicado: (2015)

Awareness, Attitudes, and Practices Toward Meningococcal B Vaccine among Pediatricians in Italy
por: Ferrara, Pietro, et al.
Publicado: (2018)

Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions
por: Bechini, Angela, et al.
Publicado: (2014)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

ROLE OF MENINGOCOCCAL ENDOTOXIN IN MENINGOCOCCAL PURPURA
por: Davis, Charles E., et al.
Publicado: (1974)

Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study
por: Miglietta, Alessandro, et al.
Publicado: (2019)

Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13
por: Neri, Arianna, et al.
Publicado: (2015)

Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges
por: Ferrara, Pietro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lbvq5niv22gij52vlpnqtqus12